At Insmed we are on a mission to transform the lives of patients battling serious rare diseases. We are developing novel, targeted therapies to help serve the critical unmet needs of these patients. In concert with developing therapeutic solutions, we are committed to improving the entire patient experience, from diagnosis and treatment to everyday living.
The QPPV will establish and maintain Insmed’s PV system to ensure compliance with all legal and regulatory requirements in the EU for the applicable Marketing Authorisations. The QPPV will be responsible to maintain oversight of the safety profiles and any emerging safety concerns in relation to the medicinal products for which Insmed holds authorisations in the EU and will be the point of contact with all EMA/EU competent authorities related to safety.